cell therapies | pharmaphorum

Tuesday 30 June 2026

cell therapies

News

ASCO26: In vivo CAR-Ts in the spotlight

ASCO26: In vivo CAR-Ts in the spotlight

Data at ASCO on in vivo CAR-Ts from Kelonia and Legend add to the excitement about the emerging therapy class in both blood cancers and solid tumours.

Oncology

Cancer cell and T-cell

CAR-NK cell therapies for solid tumours: Closing the gap bet...

CAR-NK cell therapies are frequently misunderstood, despite growing clinical and preclinical data supporting their potential.

R&D

lady listening to audio

Biotech’s biggest challenge isn’t scientific, but political ...

We speak to James Roosevelt Jr, a longtime healthcare leader, former associate commissioner of social security for retirement policy & grandson of FDR

News

Iovance cuts staff on slower cell therapy sales growth

Iovance cuts staff on slower cell therapy sales growth

Iovance will slash 19% of its headcount in a restructuring that follows slower-than-expected sales growth for melanoma cell therapy Amtagvi.

News

ADA: Vertex closer to weaning type 1 diabetics off insulin

ADA: Vertex closer to weaning type 1 diabetics off insulin

A cell therapy developed by Vertex Pharma has allowed 10 of 12 patients with type 1 diabetes to control their blood sugar without insulin.

R&D

drop white serum cream

Cell therapy transportation and storage with hydrogels

Hydrogels are revolutionising cell therapy storage – discover how they tackle cold chain challenges and reduce costs while preserving cell viability.